We’re thrilled to announce that LCS7 has signed MEGIN, the world leader in magnetoencephalography (MEG) technology. MEG is a breakthrough, non-invasive brain imaging solution that measures the brain’s tiny magnetic fields in real time. Unlike traditional scans, MEG captures millisecond-by-millisecond brain activity with unmatched accuracy — helping doctors pinpoint epileptic seizure zones, guide safer brain tumor surgeries, and even detect early signs of dementia.

With more than three decades of innovation and clinical validation, MEGIN is redefining how brain health is diagnosed and treated worldwide. Their systems are already trusted by leading hospitals and research centers, and now with LCS7’s partnership, they’re ready to scale this game-changing technology to new heights.